United States· US:71335-2114_fc506a9a-8d99-f22b-e053-6394a90ad6d9
Sucralfate
A sucralfate product containing sucralfate, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Sucralfate is registered in 13 of 19 countries.
Countries holding a registration under ATC A02BX02 (sucralfate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Sucralfate · ATC A02BX02
13 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sucralfate costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sucralfate · price per daily dose (4 g)
USD · FX 28 Sept 2026
- IT Italy$0.62
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SUCRALFATE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- A02BX02
- ATC class
- Sucralfate
- Defined daily dose
- 4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 18
- ndc11713352114028 TABLET in 1 BOTTLE, PLASTIC (71335-2114-0)
- ndc117133521141100 TABLET in 1 BOTTLE, PLASTIC (71335-2114-1)
- ndc11713352114260 TABLET in 1 BOTTLE, PLASTIC (71335-2114-2)
- ndc11713352114330 TABLET in 1 BOTTLE, PLASTIC (71335-2114-3)
- ndc11713352114420 TABLET in 1 BOTTLE, PLASTIC (71335-2114-4)
- ndc117133521146150 TABLET in 1 BOTTLE, PLASTIC (71335-2114-6)
- ndc11713352114790 TABLET in 1 BOTTLE, PLASTIC (71335-2114-7)
- ndc11713352114840 TABLET in 1 BOTTLE, PLASTIC (71335-2114-8)
- ndc117133521149120 TABLET in 1 BOTTLE, PLASTIC (71335-2114-9)
- ndc1171335-2114-0
- ndc1171335-2114-1
- ndc1171335-2114-2
- ndc1171335-2114-3
- ndc1171335-2114-4
- ndc1171335-2114-6
- ndc1171335-2114-7
- ndc1171335-2114-8
- ndc1171335-2114-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
504 interactions on record for sucralfate.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sucralfate · interactions on record
504 records
- 5 severe
- 116 moderate
- 46 minor
- 337 info
Most severe, free to view
- ParicalcitolA11CC07severe
- ParicalcitolH05BX02severe
- DoxercalciferolH05BX03severe
- DolutegravirJ05AJ03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sucralfate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAlsucralOrion Corporation Orion Pharma
- CanadaAPO-SUCRALFATE - TAB 1GAPOTEX INC
- SwedenAndapsin 1 g TablettOrion Corporation
- ItalyANTEPSINLABORATORI BALDACCI S.P.A.
- FranceKEAL 1 g, comprimé sécableEXOD
- NorwayAntepsinOrion Corporation Orion Pharma
- CzechiaGASTROFAIT
- NetherlandsPeptonorm 1 g, tablettenUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Sucralan, Sucralfat Genericon
- Germany · Sucrabest
- Denmark · Antepsin, Peptonorm
- Finland · Antepsin, Peptonorm
- France · Keal, Ulcar
- United Kingdom (Northern Ireland) · Sucralfate Roma Pharmaceuticals
- Greece · Peptonorm
- Hungary · Peptonorm
- Iceland · Antepsin
- Italy · Antepsin, Sucralfato Doc Generici
- Netherlands · Sucralfaat Sandoz, Sucralfaat Teva
- Norway · Antepsin
- Portugal · Sucralfato Generis, Sucralfato Jaba
- Sweden · Andapsin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b249d16f-c2e7-4620-ac1b-190d33e53a6e GET /v1/drugs/b249d16f-c2e7-4620-ac1b-190d33e53a6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "SUCRALFATE",
"productndc": "71335-2114",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "ANDA074415",
"marketing_category": "ANDA"
}See everything about sucralfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.